Medical applications of electroporation

IEEE Transactions on Plasma Science

Volumn 28, Issue 1, 2000, Pages 206-223

  Dev, Sukhendu B ^a   Rabussay, Dietmar P ^a   Widera, Georg ^a   Hofmann, Gunter A ^a  

^a Inovio Biomedical Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR SYSTEM; CELL MEMBRANES; CONTROLLED DRUG DELIVERY; DNA; ELECTRIC FIELDS; MEDICAL APPLICATIONS; ONCOLOGY; TISSUE;

CHEMOTHERAPEUTIC DRUGS; ELECTROPORATION; GENE THERAPY APPLICATION; NATURAL CELLULAR TRANSMEMBRANE POTENTIAL; TRANSDERMAL DRUG DELIVERY;

ELECTROCHEMISTRY;

EID: 0033732216     PISSN: 00933813     EISSN: None     Source Type: Journal    
DOI: 10.1109/27.842905     Document Type: Article

References (171)

1. J. C. Weaver and Y. A. Chizmadzhev, "Theory of electroporation: A review," Bioelectrochem. Bioenerget., vol. 41, pp. 135-160, 1996.
2. J. A. Nikoloff, Ed., "Electroporation protocols for microorganisms," in Methods in Molecular Biology. Totowa, NJ: Humana, 1995, vol. 47.
3. _, "Animal cell electroporation & electrofusion protocols," in Methods in Molecular Biology. Totowa, NJ: Humana, 1995, vol. 48.
4. "Plant cell electroporation & electrofusion protocols," in Methods in Molecular Biology. Totowa, NJ: Humana, 1995, vol. 55.
5. D. C. Chang, B. M. Chassy, J. A. Saunders, and A. E. Sowers, Eds., Guide to Electroporation and Electrofusion. San Diego, CA: Academic, 1992.
6. E. Neumann, A. E. Sowers, and C. A. Jordan, Eds., Electroporation and Electrofusion in Cell Biology. New York: Plenum, 1989.
7. U. Zimmermann and G. A. Neil, Eds., Electromanipulation of Cells. Boca Raton, FL: CRC Press, 1996.
8. P. T. Lynch and M. R. Davey, Eds., Electrical Manipulation of Cells. New York: Chapman & Hall, 1996.
9. G. A. Hofmann, "Instrumentation and electrodes for in vivo electroporation," in Methods in Molecular Medicine, M. J. Jaroszeski, R. Heller, and R. Gilbert, Eds. Totowa, NJ: Humana, to be published.
10. M. Okino and H. Mohri, "Effects of a high-voltage electrical impulse and an anticancer drug on in vivo growing tumors," Jpn. J. Cancer Res., vol. 78, pp. 1319-1321, 1987.
11. J. J. Belehradek, S. Orlowski, B. Poddevin, C. Paoletti, and L. M. Mir, "Electrochemotherapy of spontaneous mammary tumors in mice," Eur. J. Cancer, vol. 27, pp. 73-76, 1991.
12. G. A. Hofmann, S. B. Dev, G. S. Nanda, and D. Rabussay, "Electroporation therapy of solid tumors," Crit. Rev. Therapeutic Drug Carrier Syst., vol. 16, no. 6, pp. 523-569, 1999.
13. L. M. Mir, H. Banoun, andC. Paoletti, "Introduction of definite amounts of nonpermeant molecules into living cells after electropermeabilization: direct access to the cytosol," Exper. Cell Res., vol. 175, pp. 15-25, 1988.
14. S. Orlowski, J. J. Belehradek, C. Paoletti, and L. M. Mir, "Transient electropermeabilization of cells in culture: Increase of the cytotoxicity of anticancer drugs," Biochem. Pharmacol., vol. 37, no. 24, pp. 4727-4733, 1988.
15. G. S. Nanda, R. A. Merlock, G. A. Hofmann, and S. B. Dev, "Membrane permeabilization of MCF-7 cells by electrical pulses enhances cytotoxicity of anticancer drugs," in Proc. Amer. Assoc. Cancer Research, 1997, p. 260.
16. H. Yabushita, K. Yoshikawa, M. Hirata, H. Furuya, T. Hojyoh, H. Fukatsu, M. Noguchi, and M. Nakanishi, "Effects of electrochemotherapy on CaSki cells derived from a cervical squamous cell carcinoma," Gynecol. Oncol., vol. 65, no. 2, pp. 297-303, 1997.
17. M. Kambe, D. Arita, H. Kikuchi, T. Funato, F. Tezuka, M. Gamo, Y. Murakawa, and R. Kanamaru, "Enhancing the effect of anticancer drugs against the colorectal cancer cell line with electroporation," Tohoku J. Exper. Med., vol. 180, no. 2, pp. 161-171, 1990.
18. G. S. Nanda, F. X. Sun, G. A. Hofmann, R. M. Hoffman, and S. B. Dev, "Electroporation therapy of human larynx tumors Hep-2 implanted in nude mice "Anticancer Res., vol. 18, pp. 999-1004, 1998.
19. G. S. Nanda, R. A. Merlock, G. A. Hofmann, and S. B. Dev, "A novel and effective therapy for prostate cancer," in Proc. Amer. Assoc. Cancer Res., vol. 39, 1998, p. 472.
20. L. G. Salford, B. R. R. Persson, A. Brun, C. P. Ceberg, P. Kongstad, and L. M. Mir, "New brain tumor therapy combining bleomycin with in vivo electropermeabilization," Biochem. Biophys. Res. Commun., vol. 194, no. 2, pp. 938-943, 1993.
21. S. B. Dev, G. S. Nanda, Z. An, X. Wang, R. M. Hoffman, and G. A. Hofmann, "Effective electroporation therapy of human pancreatic tumors implanted in nude mice," Drug Delivery, vol. 4, no. 4, pp. 293-299, 1997.
22. M. J. Jaroszeski, R. A. Gilbert, and R. Heller, "In vivo antitumor effects of electrochemotherapy in a hepatoma model," Biochim. Biophys. Acta, vol. 1334, pp. 15-18, 1997.
23. H. Hasegawa, M. Kano, N. Hoshi, K. Watanabe, E. Satoh, B. Nakayama, and T. Suzuki, "An electrochemotherapy model for rat tongue carcinoma," J. Oral Pathol. Med., vol. 27, pp. 249-254, 1998.
24. M. Hyacinthe, M. J. Jaroszeski, V. V. Dang, D. Coppola, R. C. Karl, R. A. Gilbert, and R. Heller, "Electrically enhanced drug delivery for the treatment of soft tissue sarcoma," Cancer, vol. 85, no. 2, pp. 409-413, 1999.
25. L. R. Ramirez, S. Orlowski, G. Bindoula, R. Dzodic, P. Ardouin, C. Bognel, J. Belehradek, J.-N. Munck, and 1. M. Mir, "Electrochemotherapy on liver tumours in rabbits," Br. J. Cancer, vol. 77, no. 12, pp. 2104-2111, 1998.
26. L. M. Mir, M. Belehradek, C. Domenge, S. Orlowski, B. Poddevin, J. J. Belehradek, G. Schwaab, B. Luboinski, and C. Paoletti, "Electrochemotherapy, a novel antitumor treatment: First clinical trial," Comptes Rendus Acad. Sci. III Paris, vol. 313, no. 3, pp. 613-618, 1991.
27. M. Belehradek, C. Domenge, B. Luboinski, S. Orlowski, J. Belehradek, and L. M. Mir, "Electrochemotherapy, a new antitumor treatment," Cancer, vol. 72, no. 12, pp. 3694-3700, 1993.
28. R. Heller, M. J. Jaroszeski, L. F. Glass, J. L. Messina, D. P. Rapaport, R. C. DeConti, N. A. Fenske, R. A. Gilbert, L. M. Mir, and D. S. Reinigen, "Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy," Cancer, vol. 77, no. 5, pp. 964-966, 1996.
29. G. A. Hofmann, S. B. Dev, and G. S. Nanda, "Electrochemotherapy: Transition from laboratory to the clinic," IEEE Eng. Med. Biol., vol. 15, no. 6, pp. 124-132, 1996.
30. G. A. Hofmann, S. B. Dev, S. Dimmer, and G. S. Nanda, "Electroporation therapy: A new approach for the treatment of head and neck cancer," IEEE Trans. Biomed. Eng., vol. 46, no. 6, pp. 752-759, 1999.
31. C. Domenge, S. Orlowski, B. Luboinski, T. DeBaere, G. Schwaab, J. Belehradek, and L. M. Mir, "Antitumor electrochemotherapy: New advances in the clinical protocol," Cancer, vol. 77, no. 5, pp. 956-963, 1996.
32. P. Giraud, J. M. Bachaud, J. Teissie, and M. P. Rois, "Effects of electrochemotherapy on cutaneous metastases of human malignant melanoma," Int. J. Radiat. Oncol. Biolog. Phys., vol. 36, no. 5, p. 285, 1996.
33. Z. Rudolf, B. Stabuc, M. Cemazar, D. Miklavcic, L. Vodovnik, and G. Sersa, "Electrochemotherapy with bleomycin. The first clinical experience in malignant melanoma patients," Radiat. Oncol., vol. 29, pp. 229-235, 1995.
34. R. Heller, "Treatment of cutaneous nodules using electrochemotherapy," J. Florida Med. Assoc., vol. 82, pp. 147-150, 1995.
35. W. R. Panje, M. P. Hier, G. R. Garman, E. Harrell, A. Goldman, and I. Bloch, "Electroporation therapy of head and neck cancer," Ann. Otol., Rhinol. Laryngol., vol. 107, no. 9, pp. 779-785, 1998.
36. P. Goldfarb, M. Biel, E. Hanna, J. Houck, D. Klotch, C. Nathan, W. Panje, T. Tobbins, G. Shaw, S. El-Sayed, M. Hier, V. Jones, J. Nasser, and A. Rice, "A Phase II study using electroporation (EPT) and intratumoral bleomycin in patients with recurrent head and neck cancer: A safe and active treatment approach," in Proc. Amer. Soc. Clin. Oncol, vol. 18, 1999, abstract no. 1535, p. 397.
37. G. Sersa, B. Stubec, M. Cemazar, B. Jancar, D. Miklavcic, and Z. Rudolf, "Electrochemotherapy with cisplatin: Potentiation of local cisplatin antitumour effectiveness by application of electric pulses in cancer patients," Eur. J. Cancer, vol. 34, no. 8, pp. 1213-1218, 1998.
38. J. S. Lazo and S. M. Sebti, "Bleomycin," Cancer Chemo. Biolog. Response Modifiers, vol. 17, pp. 40-45, 1997.
39. K. Stubbe, J. W. Kozarich, W. Wu, and D. E. Vanderwall, "Bleomycin: A structural model for specificity binding and double strand cleavage," Acc. Chem. Res., vol. 29, pp. 322-330, 1996.
40. D. E. Vanderwall, S. M. Lui, W. Wu, C. J. Turner, J. W. Kozarich, and J. Stubbe, "A model of the structure of HOO-Co bleomycin bound to d(CCAGTACTGG): Recognition at the d(GpT) site and implications for double-stranded DNA cleavage," Chem. Biol., vol. 4, pp. 373-387, 1997.
41. L. M. Mir, O. Tounekti, and S. Orlowski, "Bleomycin: Revival of an old drug," Gen. Pharmacol., vol. 27, no. 5, pp. 745-748, 1996.
42. D. O. Slosman, P. M. Costabella, M. Roth, G. Werlen, and B. S. Polla, "Bleomycin primes monocytes-macrophages for superoxide production," Eur. Respirat. J., vol. 3, no. 7, pp. 772-778, 1990.
43. A. H. Wyllie, J. F. R. Kerr, and A. R. Currie, "Cell death: The significance of apoptosis," Int. Rev. Cytol., vol. 68, pp. 251-300, 1980.
44. O. Tounekti, G. Pron, J. Belehradek, and L. M. Mir, "Bleomycin, an apoptosis-mimetic drug that induces two types of cell death depending on the number of molecules internalized," Cancer Res., vol. 53, pp. 5462-5469, 1993.
45. Workshop 2405, presented at the Impact of Apoptosis 50th Annu. Meeting AACC, Chicago, IL, Aug. 2-6, 1998.
46. Y. Xu, C. Bradham, D. A. Brenner, and M. J. Czaja, "Hydrogen peroxide-induced liver cell necrosis is dependent on AP-1 activation," Amer. J. Physiol., vol. 273, pp. 795-803, 1997.
47. K. el Oaugari, J. Teissie, and H. Benoist, "Glycophorin A protects K562 cells from natural killer cell attack. Role of angiogenesis," J. Biol. Chem., vol. 270, pp. 26970-26975, 1995.
48. Y. Mouneimne, P. F. Tosi, Y. Gazitt, and C. Nicolau, "Electro-insertion of xeno-glycophorin into red blood cell membrane," Biochem. Biophys. Res. Commun., vol. 159, pp. 34-40, 1989.
49. Y. Mouneimne, P. F. Tosi, R. Barhouni, and C. Nicolau, "Electroinsertion of xeno proteins in red blood cell membranes yields a long lived protein carrier in circulation," Biochim. Biophys. Acta, vol. 1066, pp. 83-89, 1991.
50. S. Raffy and J. Teissie, "Electroinsertion of glycophorin A in interdigitation fusion giant unicellular lipid vesicles," J. Biol. Chem., vol. 272, pp. 25524-25530, 1997.
51. Y. Mouneimn, P. F. Tose, R. Barhouni, and C. Nicolau, "Electroinsertion of full length recombinant CD4 into red blood cell membrane," Biochim. Biophys. Acta, vol. 272, pp. 53-58, 1990.
52. M. Zeira, P. F. Tose, Y. Mouneimn, J. Lazarte, L. Sneed, D. J. Volsky, and C. Nicolau, "Full-length CD4 electroinserted in the erythrocyte membrane as a long-lived inhibitor of infection by human immunodeficiency virus," in Proc. Nat. Acad. Sci., vol. 88, 1991, pp. 4409-4413.
53. F. B. Hollinger, Y. Mouneimne, C. Lahart, P. F. Tose, D. Dimitrov, and C. Nicolau, "Life span of circulating membrane CD4 inserted into the plasma membranes of autologous red blood cells of HIV-infected subjects," J. Acquired Immune Def. Synd. Human Retrovirol., vol. 9, pp. 126-132, 1995.
54. S. B. Dev and G. A. Hofmann, "Clinical applications of electroporation," in Electrical Manipulation of Cells, P. T. Lynch and M. R. Davey, Eds: Chapman Hall, 1996, ch. 9, pp. 185-199.
55. G. S. Nanda, "Development of cellular systems as carriers of drugs for therapeutic applications," Ph.D. dissertation, University of Bombay, India, 1993.
56. Y. Mouneimne, R. Barhouni, T. Myers, S. Slogoff, and C. Nicolau, "Stable rightward shifts of the oxyhemoglobin disassociation curve induced by encapsulation of insitol hexaphostate in red blood cells using electroporation," FEBS Lett., vol. 275, pp. 117-120, 1990.
57. Y. Ogata, H. Goto, T. Kimura, and H. Fukui, "Development of neo red cells (NRC) with the enzymatic reduction system of methemoglobin," Artif. Cells Blood Substit. Immobil. Biotechnol., vol. 25, pp. 417-727, 1997.
58. Y. Ogata, H. Goto, K. Sakaguchi, M. Suzuki, K. Ohsaki, K. Suzuki, A. R. Saniabadi, and T. Kamitani, "Characteristics of neo red cells, their function and safety: In vivo studies, "Artif. Cells Blood Substit. Immobil. Biotechnol., vol. 22, pp. 875-881, 1994.
59. N. Crawford and N. Chronos, "Electro-encapsulating drugs within blood platelets: local delivery to injured carotid arteries during angioplasty," Semin. Interven. Cardiol., vol. 1, pp. 91-102, 1996.
60. A. Banning, L. Brewer, M. Wendt, P. H. Groves, H. Cheadle, W. J. Penny, and N. Crawford, "Local delivery of platelets with encapsulated iloprost to balloon injured pig carotid arteries: Effect on platelet deposition and neointima formation," Thromb Haemost, vol. 7, pp. 190-196, 1997.
61. Y. Oshima, T. Sakamoto, K. Sonoda, H. Yoshida, T. Ishibashi, and H. Inomata, "Effect of electric pulses and antiproliferative drugs on cultured retinal pigment epithelial cells," Curr. Eye Res., vol. 16, pp. 64-70, 1997.
62. T. Sakamoto, Y. Oshima, M. Sakamoto, Y. I. Kawano, T. Ishibashi, H. H. Inomata, and Y. Ohnishi, "Electroporation and bleomycin in galucomafiltering surgery," Invest. Ophthalmol. Vis. Sci., vol. 38, pp. 2864-2868, 1997.
63. Y. Oshima, T. Sakamoto, T. Nakamura, Y. Tahara, Y. Goto, T. Ishibashi, and H. Inomata, "The comparative benefits of glaucoma filtering surgery with an electric-pulse targeted drug delivery system demonstrated in an animal model," Ophthalmology, vol. 106, pp. 1140-1146, 1999.
64. Y. Oshima, T. Sakamoto, I. Yamanaka, T. Nishi, T. Ishibashi, and H. Inomata, "Targeted gene transfer to corneal endothelium in vivo by electric pulse," Gene Therapy, vol. 5, pp. 1347-1354, 1998.
65. B. Hofling, P. Gonschior, B. Mack, F. Gerheuser, G. Bauriedel, A. Nerlich, U. Welsh, and J. B. Simpson, "Current status of directional coronary atherectomy in interventional cardiology," Z. Kardiol., vol. 80, pp. 25-34, 1991.
66. J. R. Margolis, L. Morgensen, S. Mehta, C. Chen, and D. Krauthamer, "Diffuse embolization following percutaneous transluminal coronary angioplasty of occluded vein grafts: The blush phenomenon," Clin. Cardiol., vol. 14, pp. 489-493, 1991.
67. P. W. Serruys, B. H. Strauss, H. M. Van Beusekom, and W. J. Van der Giessen, "Stenting of coronary arteries: Has a modern Pandora's box been opened?," J. Amer. Coll. Cardiol. [Suppl.], vol. 17, pp. 143-154.
68. D. C. Warth, M. B. Leon, W. O'Neill, N. Zacca, N. L. Polisssar, and M. Buchbinder, "Rotational atherectomy multicenter registry: Acute results, complications and 6-month angiographie follow-up in 709 patients," J Amer. Coll. Cardiol., vol. 24, pp. 641-648, 1994.
69. H. Alfke, H. J. Wagner, C. Calmer, and K. J. Klose, "Local intravascular drug delivery: in vitro comparison of three catheter systems," Cardiovasc. Intervent. Radiol., vol. 21, no. 1, pp. 50-56, 1998.
70. P. Barath, A. Popov, G. L. Dillehay, G. Matos, and J. McKiernan, "Infiltrator angioplasty balloon catheter: a device for combined angioplasty and intramural site-specific treatment," Cathet. Cardiovasc. Diagn., vol. 41, no. 3, pp. 333-341, 1997.
71. R. G. Welsh, J. E. Fowler, and J. E. Shapland, "lontophoretic drug delivery system," Semin. Int. Cardiol., vol. 1, no. 1, pp. 40-42, 1996.
72. E. Camenzind, M. J. Kutryk, and P. W. Serruys, "Use of locally delivered conventional drug therapies," Semin. Int. Cardiol., vol. 1, no. 7, pp. 67-76, 1996.
73. A. Dick, W. Kromen, E. Jungling, S. Grosskortenhaus, H. Kammermeier, D. Vorwerk, and L. R. W. Günther, "Quantification of horseradish peroxidase delivery into the arterial wall in vivo as a model of local drug treatment: Comparison between a porous and a gel-coated balloon catheter," Cardiovasc. Intervent. Radiol., vol. 22, no. 5, pp. 389-393, 1999.
74. N. A. F. Chronos, K. A. Robinson, E. Schieffer, N. Crawford, S. B. Dev, G. A. Hofmann, J. E. Brown, and S. B. King III, "Enhanced uptake of propidium iodide marker into nuclei of SMC in pig aorta in vitro and pig carotid artery in vivo, by direct vessel wall electroporation," in Proc. Cleveland Clinic Found. Restenosis Summit VII, 1995, abstract 32, p. 32.
75. N. B. Dev, T. J. Preminger, G. A. Hofmann, and S. B. Dev, "Sustained local delivery of heparin to the rabbit arterial wall with an electroporation catheter," Catheter. Cardiovasc. Diag., vol. 45, pp. 337-345, 1998.
76. D. Baumgart, U. Quast, and R. Erbel, "Intravascular irradiation in the combined therapy and prevention of restenosis," Herz, vol. 22, no. 6, pp. 335-346, 1997.
77. R. Virmani, A. Barb, A. J. Carter, and R. M. Jones, "Comparative pathology: Radiation-induced coronary artery disease in man and animals," in Semin. Int. Cardiol., vol. 3, 1998, pp. 163-172.
78. S. B. Dev, F. J. Giordano, and D. L. Brown, "In vivo delivery of gene to rabbit carotid artery by electroporation," in Proc. 3rd U.S. Jpn. Symp. Drug Delivery Systems, 1995, abstract 38, p. 43.
79. J. F. Symes, D. W. Losordo, P. R. Vale, K. G. Lathi, D. D. Esakof, M. Mayskiy, and J. M. Isner, "Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease," Ann. Thorac. Surg., vol. 68, no. 3, pp. 830-837, 1999.
80. M. R. Prausnitz, "The effects of electric current applied to skin: A review for transdermal drug delivery," Adv. Drug Delivery Rev., vol. 18, pp. 395-425, 1996.
81. A. K. Banga, Electrically Assisted Transdermal and Topical Drug Delivery. London, U.K.: Taylor & Francis, 1998.
82. A. K. Banga and M. R. Prausnitz, "Assessing the potential of skin electroporation for the delivery of protein and gene based drugs," Trends Biotechnol., vol. 16, pp. 408-412, 1998.
83. H. Inada, A. H. Ghanem, and W. I. Higuchi, "Studies on the effects of applied voltage and duration on human epidermal membrane alteration/recovery and the resultant effects upon iontophoresis," Pharm. Res., vol. 11, pp. 687-697, 1994.
84. M. R. Prausnitz, V. G. Bose, R. Langer, and J. C. Weaver, "Electroporation of mammalian skin - A mechanism to enhance transdermal drug delivery," in Proc. Nat. Acad. Sci. USA. vol. 90, 1993, pp. 10504-10508.
85. J. C. Weaver and Y. Chizmadzhev, "Electroporation," in Biological Effects of Electromagnetic Fields, 2nd ed, C. Polte and E. Postow, Eds. Boca Raton, FL: CRC Press, 1996, pp. 247-274.
86. J. C. Weaver, "Electroporation: A general phenomenon for manipulating cells and tissues," J Cell. Biochem., vol. 51, pp. 426-435, 1993.
87. T. C. Tomov, "Quantitative dependence of electroporation on the pulse parameters," Bioelectrochem. Bioenerg., vol. 37, pp. 101-107, 1995.
88. M. R. Prausnitz, E. R. Edelman, J. A. Gimm, R. Langer, and J. C. Weaver, "Transdermal delivery of heparin by skin electroporation," Biotechnology, vol. 13, pp. 1205-1209, 1995.
89. D. B. Bommannan, J. Tamada, L. Leung, and R. O. Potts, "Effect of electroporation on transdermal iontophoretic delivery of luteinizing hormone releasing hormone (LHRH) in vitro," Pharm. Res., vol. 11, pp. 1809-1814, 1994.
90. A. V. Badkar, G. V. Betageri, G. A. Hofmann, and A. K. Banga, "Enhancement of transdermal iontophoretic delivery of a liposomal formulation of colchicine by electroporation," Drug Delivery, vol. 6, pp. 111-115, 1999.
91. G. A. Hofmann, W. V. Rustrum, and K. S. Suder, "Electro-incorporation of microcarriers as a method for the transdermal delivery of large molecules," Bioelectrochem. Bioenerg., vol. 38, pp. 209-222, 1995.
92. L. Zhang, L. N. Li, Z. L. An, R. M. Hofmann, and G. A. Hofmann, "In vivo transdermal delivery of large molecules by pressure-mediated electroincorporation and electroporation: A novel method for drug and gene delivery," Bioelectrochem. Bioenerg., vol. 42, pp. 283-292, 1997.
93. L. Zhang, S. Lerner, W. V. Rustrum, and G. A. Hofmann, "Electroporation-mediated topical delivery of vitamin C for cosmetic applications," Bioelectrochem. Bioenerg., vol. 48, pp. 453-461, 1999.
94. R. Vanbever, E. Le Boulenge, and V. Preat, "Transdermal delivery of fentanyl by electroporation. 1. Influence of electrical factors," Pharm. Res., vol. 13, pp. 559-565, 1996.
95. U. Pliquett and J. C. Weaver, "Electroporation of human skin: Simultaneous measurement of changes in the transport of two fluorescent molecules and in the passive electrical properties," Bioelectrochem. Bioenerg., vol. 39, pp. 1-12, 1996.
96. L. Zhang and G. A. Hofmann, "Electric pulse mediated transdermal drug delivery," Proc. Int. Symp. Control Ret. Bioact. Mater., vol. 24, 1997.
97. R. Vanbever, N. Lecouturier, and V. Preat, "Transdermal delivery of metoprolol by electroporation," Pharm. Res., vol. 11, pp. 1657-1662, 1994.
98. M. P. Cruz, S. L. Eeckhoudt, R. K Verbeeck, and V. Preat, "Transdermal delivery of flurbiprofen in the rat by iontophoresis and electroporation," Pharm. Res., vol. 14, p. S309, 1997.
99. S. Wang, M. Kara, and T. R. Krishnan, "Topical delivery of cyclosporin a coevaporate using electroporation technique," Drug Dev. Ind. Pharm., vol. 23, pp. 657-663, 1997.
100. J. E. Riviere, N. A. Monteiroriviere, R. A. Rogers, D. Bommannan, J. A. Tamada, and R. O. Potts, "Pulsatile transdermal delivery of LHRH using electroporation: Drug delivery and skin toxicology," J. Control Release, vol. 36, pp. 229-233, 1995.
101. S.-L. Chang, G. A. Hofmann, L. Zhang, and A. K. Banga, "Electrically assisted transdermal delivery of a salmon calcitonin formulation," presented at the 1998 Annu. Meeting American Association of Pharmaceutical Scientists, San Francisco, CA.
102. R. Bergan, Y. Connell, B. Fahmy, and L. Neckers, "Electroporation enhances c-myc antisense oligodeoxynucleotide efficacy," Nucleic Acids Res., vol. 21, pp. 3567-3573, 1993.
103. R. Bergan, F. Hakim, G. N. Schwartz, E. Kyle, R. Cepada, J. M. Szabo, D. Fowler, R. Gress, and L. Neckers, "Electroporation of synthetic oligodeoxynucleotides: A novel technique for ex vivo bone marrow purging," Blood, vol. 88, pp. 731-741, 1996.
104. S. T. Crooke, "Delivery of oligonucleotides and polynucleotides," J. Drug Targeting, vol. 3, pp. 185-190, 1995.
105. Y. S. Jong, J. S. Jacob, K. P. Yip, G. Garner, E. Seitelman, M. Whitney, S. Montgomery, and E. Mathiowitz, "Controlled release of plasmid DNA," J. Control Rel., vol. 47, pp. 123-124, 1997.
106. T. E. Zewert, U. F. Pliquett, R. Langer, and J. C. Weaver, "Transdermal transport of DNA antisense oligonucleotides by electroporation," Biochem. Biophys. Res. Commun., vol. 212, pp. 286-292, 1995.
107. V. Regnier, A. Tahiri, N. Andre, M. Lamaitre, V. Preat, and T. L. Doan, "Delivery of 3′-protected phosphodiester oligodeoxynucleotides to the skin," Pharm. Res., vol. 14, p. S - 640, 1997.
108. D. B. Bommannan, T. Chen, R. O. Potts, and O. Wong, "Pulsed transport of subtance through tissue using electrical pulse to cause electroporation - Then using passive diffusion or iontophoresis with subsequent pulses applied after hours or even days," Assignee: Cygnus, 1996.
109. J. Kost, U. Pliquett, S. Mitragotri, A. Yamamoto, R. Langer, and J. Weaver, "Synergistic effect of electric field and ultrasound on transdermal transport," Pharm. Res., vol. 13, pp. 633-638, 1996.
110. D. L. Sokol and A. M. Gewirtz, "Gene therapy: Basic concepts and recent advances," Crit. Rev. Eukaryot Gene Expr., vol. 6, no. 1, pp. 29-57, 1996.
111. U. Gottschalk and S. Chan, "Somatic gene therapy. Present situation and future perspective," Arzneimittelforschung, vol. 48, no. 11, pp. 1111-11 120, 1998.
112. G. U. Dachs, G. J. Dougherty, U. Stratford, and D. J. Chaplin, "Targeting gene therapy to cancer: A review," Oncol. Res., vol. 9, no. 6-7, pp. 313-325, 1997.
113. D. L. Knoell and I. M. Yim, "Human gene therapy for hereditary diseases: A review of trials," Amer. J. Health Syst. Pharm., vol. 55, no. 9, pp. 899-904, 1998.
114. R. G. Vile and S. J. Russell, "Retroviruses as vectors," Er. Med. Bull., vol. 51, no. 1, pp. 12-30, 1995.
115. W. W. Zhang, "Development and application of adenoviral vectors for gene therapy of cancer," Cancer Gene Ther., vol. 6, no. 2, pp. 113-118, 1999.
116. E. Klimatcheva, J. D. Rosenblatt, and V. Planelles, "Lentiviral vectors and gene therapy," Front Biosci., vol. 4, no. D, pp. 481-496, 1999.
117. W. Xiao, N. Chirmule, S. C. Berta, B. McCullough, G. Gao, and J. M. Wilson, "Gene therapy vectors based on adeno associated virus type 1," J. Virol., vol. 73, no. 5, pp. 3994-4003, 1999.
118. J. C. Glorioso, N. A. DeLuca, and D. J. Fink, "Development and application of herpes simplex virus vectors for human gene therapy," Annu. Rev. Microbiol, vol. 49, pp. 675-710, 1995.
119. K. Lundstrom, "Alphaviruses as tools in neurobiology and gene therapy," Recept. Signal Transduct. Res., pp. 673-686, 1999.
120. D. D. Patel, C. A. Ray, R. P. Drucker, and D. J. Pickup, "A pox virus-derived vector that directs high levels of expression of cloned genes in mammalian cells," in Proc. Nat. Acad. Sci. USA, vol. 85, 1988, pp. 9431-9435.
121. R. P. DeMatteo, H. Yeh, M. Friscia, D. Caparrelli, C. Burke, N. Desai, G. Chu, J. F. Markmann, S. E. Raper, and C. F. Barker, "Cellular immunity delimits adenoviral gene therapy strategies for the treatment of neoplastic diseases," Ann. Surg. Oncol., vol. 6, no. 1, pp. 88-94, 1999.
122. D. A. Muruve, M. J. Barnes, I. E. Stillman, and T. A. Libermann, "Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in vivo," Human Gene Therary, vol. 10, no. 6, pp. 965-967, 1999.
123. A. P. Rolland, "From genes to gene medicines: Recent advances in nonviral gene delivery," Crit. Rev. Ther. Drug Carrier Syst., vol. 15, no. 2, pp. 143-198, 1998.
124. J. Zabner, S. H. Cheng, D. Meeker, J. Launspach, R. Balfour, M. A. Perricone, J. E. Morris, J. Marshall, A. Fasbender, A. E. Smith, and M. J. Welsh, "Comparison of DNA-lipid complexes and DNA alone for gene transfer to cystic fibrosis airway epithelia in vivo," J. Clin. Invest., vol. 100, no. 6, pp. 1529-1537, 1997.
125. D. Deshpande, P. Blezinger, R. Pillai, J. Duguid, B. Freimark, and A. Rolland, "Target specific optimization of cationic lipid-based systems for pulmonary gene therapy," Pharm. Res., vol. 15, no. 9, pp. 1340-1347, 1998.
126. E. Neumann, M. Schaefer-Ridder, Y. Wang, and P. H. Hofschneider, "Gene transfer into mouse lymphoma cells by electroporation in high electric fields," EMBO J., vol. 1, no. 7, pp. 841-845, 1982.
127. H. Potter, "Electroporation in biology: Methods, applications, and instrumentation," Anal. Biochem., vol. 174, no. 2, pp. 361-373, 1988.
128. T. Nishi, K. Yoshizato, S. Yamashiro, H. Takeshima, K. Sato, K. Hamada, I. Kitamura, T. Yoshimura, H. Saya, J. Kuratsu, and Y. Ushio, "High efficiency in vivo gene transfer using intra arterial plasmid DNA injection following in vivo electroporation," Cancer Res., vol. 56, pp. 1050-1055, 1996.
129. T. Muramatsu, A. Nakamura, and H. M. Park, "In vivo electroporation: A powerful and convenient means of non viral gene transfer to tissues of living animals," animals. J. Mol. Med., vol. 1, pp. 55-62, 1998.
130. K. E. Matthews, S. B. Dev, F. Toneguzzo, and A. Keating, "Electroporation for gene therapy," in Methods in Molecular Biology, J. A. Nickoloff, Ed. Totowa, NJ: Humana, 1995, pp. 273-280.
131. A. Keating, E. Nolan, R. Filshie, and S. B. Dev, "Ex vivo stromal cell electroporation of Factor IX cDNA for treatment of hemophilia B," in Methods in Molecular Medicine, M. J. Jaroszeski, R. Heller, and R. Gilbert, Eds. Totowa, NJ: Humana, to be published.
132. A. Keating, L. Berkham, and R. Filshie, "A Phase I study of the translation of genetically marked autologous bone marrow stromal cells," Human Gene Therapy, vol. 9, pp. 591-600, 1998.
133. H. Fakhrai, O. Dorigo, D. L. Shawler, H. Lin, D. Mercola, K. L. Black, I. Royston, and R. E. Sobol, "Eradication of established intracranial rat glioma by TGF antisense gene therapy," in Proc. Nat. Acad. Sci. USA, vol. 93, 1996, pp. 2909-2914.
134. H. Fakhari, private communication.
135. A. V. Titomirov, S. Sukharev, and E. Kistanova, "In vivo electroporation and stable transformation of skin cells of newborn mice by plasmid DNA," Biochim. Biophys. Acta, vol. 1088, no. 1, pp. 131-134, 1991.
136. T. Muramatsu, O. Shibata, S. Ryoki, Y. Ohmori, and J. Okumura, "Foreign gene expression in the mouse testis by localized in vivo gene transfer," Biochem. Biophys. Res. Commun., vol. 233, no. 1, pp. 45-49, 1997.
137. H. Ochiai, H. M. Park, A. Nakamura, R. Sasaki, J. I. Okumura, and T. Muramatsu, "Synthesis of human erythropoietin in vivo in the oviduct of laying hens by localized in vivo gene transfer using electroporation," Poult. Sci, vol. 77, no. 2, pp. 299-302, 1998.
138. Y. Yamazaki, H. Fujimoto, H. Ando, T. Ohyama, Y. Hirota, and T. Noce, "In vivo gene transfer to mouse spermatogenic cells by deoxyribonucleic acid injection into seminiferous tubules and subsequent electroporation," Biol. Reprod., vol. 59, no. 6, pp. 1439-1444, 1998.
139. K. Harimoto, K. Sugimura, C. R. Lee, K. Kuratsukuri, and T. Kishimoto, "In vivo gene transfer methods in the bladder without viral vectors," Br. J. Urol., vol. 81, pp. 870-874, 1998.
140. R. Heller, M. Jaroszeski, A. Atkin, D. Moradpour, R. Gilbert, J. Wands, and C. Nicolau, "In vivo gene electroinjection and expression in rat liver," FEBS Lett., vol. 389, no. 3, pp. 225-228, 1996.
141. T. Suzuki, B.-C. Shin, K. Fujikura, T. Matsuraki, and K. Takata, "Direct gene transfer into rat liver cells by in vivo electroporation," FEBS Lett., vol. 425, pp. 436-440, 1998.
142. R. L. Harrison, B. J. Byrne, and L. Tung, "Electroporation-mediated gene transfer in cardiac tissue," FEBS Lett., vol. 435, pp. 1-5, 1998.
143. T. Nishi, T. Goto, K. Yoshizato, H. Takeshima, J.-I. Kuratsu, Y. Ushio, G. Hofmann, and S. B. Dev, "High efficiency gene transfer in solid tumors by in vivo electroporation," in Proc. 6th Int. Conf. Gene Therapy of Cancer, vol. 4, 1997, p. 56.
144. T. Nishi, T. Goto, K. Yoshizato, S. B. Dev, H. Takeshima, J. Kuratsu, G. Hofmann, and Y. Ushio, "High efficiency gene transfer into solid tumors using in vivo electroporation," in Proc. Amer. Assoc. Cancer Mtg., New Orleans, 1998, abstract 404, p. 59.
145. T. Nishi, T. Goto, K. Yoshizato, H. Takeshima, Y. Saito, M. Kochi, J.-I. Kuratsu, Y. Ushio, G. Hofmann, and S. B. Dev, "Electro-genetherapy using HSV-tk gene for experimental colon carcinoma," in Proc. Amer. Soc. Gene Therapy Meeting, Washington, DC, 1999, abstract 234, p. 60.
146. M. P. Rols, C. Delteil, M. Golzio, P. Dumond, S. Cross, and J. Teissie, "In vivo electrically mediated protein and gene transfer in murine melanoma," Nat. Biotechnol., vol. 16, no. 2, pp. 168-171, 1998.
147. H. Ahira and J. Miyazaki, "Gene transfer into muscle by electroporation," Nat. Biotechnol., vol. 16, pp. 867-870, 1998.
148. L. M. Mir, M. F. Bureau, R. Rangara, B. Schwartz, and D. Scherman, "Long-term, high level in vivo gene expression after electric pulse-mediated gene transfer into skeletal muscle," C R Acad. Sci. III, vol. 321, no. 11, pp. 893-899, 1998.
149. L. M. Mir, M. F. Bureau, J. Gehl, R. Rangara, D. Rouy, J. M. Caillaud, P. Delaere, D. Branellec, B. Schwartz, and D. Scherman, "High efficiency gene transfer into skeletal muscle by electric pulses," in Proc. Nat. Acad. Sci. USA, vol. 96, 1999, pp. 4262-4267.
150. G. Rizzuto, M. Cappelletti, D. Maione, R. Savino, D. Lazzaro, P. Costa, I. Mathiesen, R. Cortese, G. Ciliberto, R. Laufer, N. La Monica, and E. Fatton, "Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporation," in Proc. Nat. Acad. Sci. USA, vol. 96, 1999, pp. 6417-6422.
151. P. Kreiss, M. M. Bettan, J. Crouzer, and D. Scherman, "Erythropoietin secretion and physiological effect in mouse after intramuscular plasmid DNA electrotransfer," J. Gene Med., vol. 1, pp. 245-250, 1999.
152. I. Mathiesen, "Electropermeabilization of skeletal muscle enhances gene transfer in vivo," Gene Therapy, vol. 6, pp. 508-514, 1999.
153. R. W. Ellis, "New technologies for making vaccines," Vaccine, vol. 17, pp. 1596-1604, 1999.
154. L. A. Babiuk, "Broadening the approaches to developing more effective vaccines," Vaccine, vol. 17, pp. 1587-1595, 1999.
155. C. J. Burke, T. A. Hsu, and D. B. Volkin, "Formulation, stability, and delivery of live attenuated vaccines for human use," Crit. Rev. Ther. Drug Carrier Syst., vol. 16, no. 1, pp. 1-83, 1999.
156. F. Dorner and P. N. Barrett, "Vaccine technology: Looking to the future," Ann. Med., vol. 31, no. 1, pp. 51-60, 1999.
157. D. C. Tang, M. De Vit, and S. A. Johnston, "Genetic immunization is a simple method for eliciting an immune response," Nature, vol. 356, pp. 152-154, 1992.
158. J. J. Donnelly, J. B. Ulmer, J. W. Shiver, and M. A. Liu, "DNA vaccines," Annu. Rev. Immunol., vol. 15, pp. 617-648, 1997.
159. R. R. MacGregor, J. D. Boyer, K. E. Ugen, K. E. Lacy, S. J. Gluckman, M. L. Bagarazzi, M. A. Chattergoon, Y. Baine, T. J. Higgins, R. B. Ciccarelli, L. R. Coney, R. S. Ginsberg, and D. B. Weiner, "First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: Safety and host response," J. Infect. Disease, vol. 178, no. 1, pp. 92-100, 1998.
160. R. Wang, D. L. Doolan, T. P. Le, R. C. Hedstrom, K. M. Coonan, Y. Charoenvit, T. R. Jones, P. Hobart, M. Margalith, J. Ng, W. R. Weiss, M. Sedegah, C. de Taise, J. A. Norman, and S. L. Hoffman, "Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine," Science, vol. 282, pp. 476-480, 1998.
161. C. O. Tracket, M. J. Roy, G. Widera, W. F. Swain, S. Broome, and R. Edelman, "Phase 1 safety and immune response studies of a DNA vaccine encoding hepatitis B surface antigen delivered by a gene delivery device," Vaccine, vol. 17, pp. 2826-2829, 1999.
162. D. B. Weiner and R. C. Kennedy, "Genetic vaccines," Sci. Amer., vol. 281, no. 1, pp. 50-57, 1999.
163. J. A. Wolff, R. W. Malone, P. Williams, W. Chong, G. Acsadi, A. Jani, and P. L. Felgner, "Direct gene transfer into mouse muscle in vivo," Science, pt. 1, vol. 247, no. 4949, pp. 1465-1468, 1990.
164. E. Raz, D. A. Carson, S. E. Parker, T. B. Parr, A. M. Abai, G. Aichinger, S. H. Gromkowski, M. Singh, D. Lew, and M. A. Yankauckas et al., "Intradermal gene immunization: The possible role of DNA uptake in the induction of cellular immunity to viruses," in Proc. Nat. Acad. Sci. USA, vol. 91, 1994, pp. 9519-9523.
165. N. S. Yang, J. Burkholder, B. Roberts, B. Martinell, and D. McCabe, "In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment," in Proc. Nat. Acad. Sci. USA, vol. 87, 1990, pp. 9568-9572.
166. E. F. Fynan, R. G. Webster, D. H. Fuller, J. R. Haynes, J. C. Santoro, and H. L. Robinson, "DNA vaccines: Protective immunizations by parenteral, mucosal, and gene-gun inoculation," in Proc. Nat. Acad. Sci. USA, vol. 90, 1993, pp. 11 478-11 482.
167. J. J. Fischerand H. Yabuki, "Preparation of red blood cells containing exogenous hemoglobin," Artif. Cells Blood Substit. Immobil. Biotechnol., vol. 26, pp. 377-387, 1998.
168. M. Haritou, D. Yova, D. Koutsouris, and S. Loukas, "Loading of intact rabbit erythrocytes with fluorophores and the enzyme pronase by means of electroporation," Clin. Hemorheol. Microcirc., vol. 19, pp. 205-217, 1998.
169. G. Flynn, T. J. Hackett, L. McHale, and A. P. McHale, "Encapsulation of the thrombolytic enzyme, brinase, in photosensitized erythrocytes: A novel thrombolytic system based on photodynamic activation," J. Photochem. Photobiol. B, vol. 26, pp. 193-196, 1994.
170. T. Ward, D. Mooney, G. Flynn, and A. P. McHale, "Electric field-enhanced activation of hematoporphyrin derivative: Effects on a human tumour cell line," Cancer Lett., vol. 113, pp. 145-151, 1997.
171. C. Huang, W. Y. Ma, S. S. Hecht, and Z. Dong, "Inositol hexaphosphate inhibits cell transformation and activator protein 1 activation by targeting phosphatidylinositol 3′ kinase," Cancer Res., vol. 57, pp. 2873-2878, 1997 [erratum, p. 5198].